Overview |
bsm-62714r-100ul |
Human IgG Monoclonal Antibody |
WB, IHC-P, IHC-F, IF |
Human |
Specifications |
Unconjugated |
Rabbit |
KLH conjugated synthetic peptide derived from human Human IgG |
Monoclonal |
Recombinant |
IgG |
1ug/ul |
Purified by Protein A. |
10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
Shipped at 4°. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
Target |
P01857,P01859,P01860,P01861 |
G1m marker; G2m marker; G3m marker; G4m marker; HDC; Heavy chain disease protein; Human immunglobulin G; Ig gamma 1 chain C region; Ig gamma 2 chain C region; Ig gamma 3 chain C region; Ig gamma 4 chain C region; IgG heavy chain locus; IGHG1; IGHG2; IGHG3; IGHG4. |
Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens |
Application Dilution |
WB |
:1:1000-1:2000 |
IHC-P |
IHC-P:1:100-1:200 |
IHC-F |
IHC-F:1:100-1:200 |
IF |
IF:1:100-1:200 |